文献速递肾小球疾病

IgA肾病循环旁路途径裂解因子Bb与血管病变及结局相关

Circulating alternative pathway complement cleavage factor Bb is associated with vascular lesions and outcomes in IgA nephropathy.
PubMed 文献 · Nephrol Dial Transplant · 2023-01-01

这项回顾性研究纳入125例活检证实的IgA肾病患者,诊断时检测血清Bb片段浓度并随访中位16年;Bb浓度与随访末eGFR负相关、与血管及小管病理指标正相关;校正进展危险因素后,Bb≥14.3 μg/ml与ESKD风险独立相关(HR 4.76,95%CI 1.56-14.43)。

要点

  • 诊断时血清Bb片段浓度与IgA肾病随访末eGFR呈负相关。
  • Bb浓度与血管及小管组织病理学指标呈正相关。
  • 校正进展危险因素后,Bb≥14.3 μg/ml与ESKD风险相关(HR 4.76)。

核心结论

  • 诊断时血清Bb片段浓度可能预测IgA肾病长期结局,可能与内皮表面旁路途径激活有关。
  • 需进一步研究确认结果并评估Bb片段在IgA肾病管理中的作用。

研究设计与样本

  • 回顾性研究纳入125例活检证实的IgA肾病患者,年龄39.9岁、75%男性、eGFR 82 ml/min、蛋白尿0.5 g/day,1984至2010年入组,随访至少18个月。
  • 诊断时采用酶联免疫吸附试验检测血清Bb片段,病理评估采用牛津分类和全局光学评分(GOS)。

主要发现

  • 随访中位16年,42%发生慢性肾脏病≥3期,19%达到ESKD,9%死亡。
  • 血清Bb片段浓度与随访末eGFR值呈负相关,与血管及小管组织病理学指标呈正相关。
  • 单因素Cox回归中,较高Bb片段浓度与ESKD相关,同时与年龄较大、体重指数增加、动脉性高血压、较低eGFR、较高蛋白尿、E1、S1、T1-2、GOS及皮质激素治疗相关。
  • Bb≥14.3 μg/ml患者平均肾脏生存时间较短(19.5 vs 22.7年,P = .07);校正进展危险因素后关联持续(HR 4.76,95%CI 1.56-14.43)。

临床怎么用

  • 诊断时血清Bb片段浓度可能用于IgA肾病长期结局的风险评估。
  • 原文指出需进一步研究确认结果并评估Bb片段在IgA肾病管理中的作用。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Complement alternative pathway (AP) activation is linked to immunoglobulin A nephropathy (IgAN) prognosis severity, but Bb fragment's role is unclear. We examined the relationship between serum Bb fragment concentration at IgAN diagnosis and disease activity and outcomes. METHODS: This retrospective study included 125 biopsy-proven IgAN patients [age 39.9 years, 75% male, estimated glomerular filtration rate (eGFR) 82 ml/min, proteinuria 0.5 g/day] enrolled from 1984 to 2010 and followed for a minimum of 18 months. Monitoring continued until the last follow-up, end-stage kidney disease (ESKD) or death. Serum Bb fragment was measured using an enzyme-linked immunosorbent assay at diagnosis. Oxford classification and global optical score (GOS) were utilized for pathology assessment. RESULTS: Patients were followed for a median of 16 years; 42% developed chronic kidney disease stage ≥3, 19% reached ESKD and 9% died. Serum Bb fragment concentration negatively correlated with eGFR values at the last follow-up and positively with vascular and tubular histopathological indices. In univariate Cox regression analyses, higher Bb fragment concentration was associated with ESKD alongside older age, increased body mass index, arterial hypertension, lower eGFR, higher proteinuria, E1, S1, T1-2, GOS and corticotherapy. Patients with Bb levels ≥14.3 μg/ml had shorter mean kidney survival time (19.5 versus 22.7 years, P = .07); after adjusting for progression risk factors, the association persisted [hazard ratio 4.76 (95% confidence interval 1.56-14.43)]. CONCLUSIONS: Serum Bb fragment concentration at diagnosis may predict long-term IgAN outcomes, potentially due to AP activation at the endothelial surface. Further research is needed to confirm these results and evaluate Bb fragment's role in IgAN management.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Ștefan G, Jullien P, Masson I, et al. Circulating alternative pathway complement cleavage factor Bb is associated with vascular lesions and outcomes in IgA nephropathy. Nephrol Dial Transplant. 2023. PMID: 37816675. doi:10.1093/ndt/gfad163

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。